Detección de la troponina I cardiaca durante el embarazo para la identificación de enfermedades cardiovasculares y evaluación de riesgos

The present invention provides systems and methods for determining and reporting the cardiac troponin I (cTnI) concentration in a sample from a pregnant woman (in the first, second, or third trimester) by determining whether the sample (cTnI) concentration is higher than a 99thpercentile cTnI concen...

Full description

Saved in:
Bibliographic Details
Main Authors SONG QUEK, Yek, SICKAN, Jaganathan, YUAN WOON, Shu, NOOR, Eliza Mohd, BESHIRI, Agim, RAVICHANDRAN, Jeganathan, SURESH, Kumar, VIGNESWARAN, Ramakrishnan, LIM, Yee Cherng
Format Patent
LanguageSpanish
Published 24.03.2021
Subjects
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online AccessGet full text

Cover

More Information
Summary:The present invention provides systems and methods for determining and reporting the cardiac troponin I (cTnI) concentration in a sample from a pregnant woman (in the first, second, or third trimester) by determining whether the sample (cTnI) concentration is higher than a 99thpercentile cTnI concentration from a corresponding first, second, or third trimester uncomplicated pregnancy control group, thereby determining if the pregnant woman has or is at risk of developing cardiovascular disease, such as gestational hypertension.
Bibliography:Application Number: ES20170735252T